🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Afya Ltd DRC (A2FY34)

B3
Currency in BRL
50.99
+2.34(+4.81%)
Closed
A2FY34 Scorecard
Full Analysis
Impressive gross profit margins
Unusual trading volume
Fair Value
Day's Range
48.7250.99
52 wk Range
41.0058.50
Key Statistics
Edit
Bid/Ask
45.00 / 51.00
Prev. Close
48.65
Open
48.72
Day's Range
48.72-50.99
52 wk Range
41-58.5
Volume
197
Average Volume (3m)
61
1-Year Change
-1.32%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
A2FY34 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Afya Ltd DRC Company Profile

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

Compare A2FY34 to Peers and Sector

Metrics to compare
A2FY34
Peers
Sector
Relationship
P/E Ratio
15.1x−0.3x10.8x
PEG Ratio
0.240.080.02
Price/Book
2.1x2.4x1.4x
Price / LTM Sales
2.8x1.9x0.9x
Upside (Analyst Target)
-18.3%19.0%
Fair Value Upside
Unlock27.7%6.4%Unlock

FAQ

What Is the Afya Ltd DRC (A2FY34) Stock Price Today?

The Afya Ltd DRC stock price today is 50.99.

What Stock Exchange Does Afya Ltd DRC Trade On?

Afya Ltd DRC is listed and trades on the B3 stock exchange.

What Is the Stock Symbol for Afya Ltd DRC?

The stock symbol for Afya Ltd DRC is "A2FY34."

What Is the Afya Ltd DRC Market Cap?

As of today, Afya Ltd DRC market cap is 8.70B.

What is Afya Ltd DRC Earnings Per Share?

The Afya Ltd DRC EPS is 6.44.

From a Technical Analysis Perspective, Is A2FY34 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.